
Pfizer’s Q4 Earnings: Will Non-COVID Drugs Propel Revenue Growth Beyond the Pandemic?
Pfizer’s Q4 Top-Line Growth: A Deep Dive into New and Non-COVID Drugs Pfizer Inc., one of the world’s leading pharmaceutical companies, reported impressive top-line growth in the fourth quarter of 2021, driven primarily by the success of its non-COVID drugs and newly acquired products. Let’s explore the significant contributors to Pfizer’s financial growth in more…